10-year oncological outcomes of EBRT versus HIFU for stage II prostate cancer: a multicenter Chang Gung research database (CGRD) study with inverse-probability-of-treatment weighting (IPTW) analysis.

Int Urol Nephrol · 2026 · PMC12999707 · PMID 41055797

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

marginally significantp = 0.053so close (0.05 < p ≤ 0.1)

9.2% respectively). Oncological outcomes (OS, CSS) In stage II prostate cancer, significantly better OS is observed in the HIFU group compared with the RT group before IPTW adjustment ( p = 0.001), but the significance is marginally significant after IPTW adjustment ( p = 0.053).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.